SecBot SecBot
8-K ·Filed Sep 18, 2026

IVFH

INNOVATIVE FOOD HOLDINGS INC
NEUTRAL
Impact 3/10
Horizonweeks Processed1mo ago SEC0001185185-26-004168
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)
Actionable Insight • Neutral

The CFO appointment and equity grant amendments are routine governance actions. Monitor the next quarterly filing for any update on share count dilution from the time-based awards and for any change-of-control discussions that could trigger acceleration.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+20d
IVFH ▼ -22.73% at T+20d
NEUTRAL call -22.73% · α vs SPY -21.82% · entry $0.2200 → $0.1700
Next anchor: T+60d in 7w
Latest observation: T+24 -12.36% FF3 residual α
Entry = T+0 close
Sep 18, 2026
via day close
T+1d
-0.14%
call -0.14% · α -0.12%
$0.2197
settled 5w ago
T+5d
-22.73%
call -22.73% · α -21.71%
$0.1700
settled 5w ago
T+20d
-22.73%
call -22.73% · α -21.82%
$0.1700
settled 12d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

Innovative Food Holdings appointed Erik Saterbo as CFO and amended the equity grants for CEO Gary Schubert and officer Argie Liarakos, converting performance-based stock awards to time-based vesting with change-of-control acceleration. The CFO hire fills a key role, but the conversion of 1.35M shares for Schubert from performance-based to time-based removes a performance hurdle, which is a modest negative for existing shareholders.

Key Facts

  • Erik Saterbo appointed CFO effective immediately with a 3-year term ending September 14, 2029.
  • Saterbo receives $225,000 annual base salary, 12% annual cash incentive, and 150,000 time-vesting restricted shares.
  • CEO Gary Schubert's performance-based grant of 1,350,000 shares converted to time-based vesting with change-of-control acceleration.
  • Argie Liarakos's performance-based grant of 150,000 shares similarly converted to time-based vesting.
  • All equity grants accelerate upon change of control, termination without cause, or resignation for good reason.

Financial Impact

No financial figures disclosed beyond executive compensation terms. The conversion of 1.5M total shares from performance-based to time-based vesting removes a performance condition, potentially accelerating dilution if shares vest on schedule.

dilutionexecutive compensation

Risk Factors

  • Conversion of performance-based grants to time-based reduces alignment with shareholder value creation.
  • Potential dilution from 1.65M total shares (Schubert 1.35M + Liarakos 150K + Saterbo 150K) vesting over time.

Investment Themes

Consumer & Retail

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001185185-26-004168
Document: 0001185185-26-004168-index-headers.html0001185185-26-004168
Document: 0001185185-26-004168-index.html0001185185-26-004168
Document: 0001185185-26-004168.txt0001185185-26-004168
2 reports for IVFH
Performance horizon
Filters
Rows
Reports for IVFH — sortable, filterable
TypeNow
Sep 18, 2026
5w ago
8-K
NEUTRAL ★ 3/10
$0.2200 $0.1700▼ −22.73%▼ −21.82%$0.1650 (−25.00%)
Apr 3, 2026
29w ago
DEFA14A
NEUTRAL ★ 3/10
$0.3268 $0.3110▼ −4.83%▼ −13.82%$0.1650 (−49.51%)
Showing 2 of 2

US Market Status

Market Closed — Opens Thu (12h 54m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 18, 2026